A leading Indian pharmaceutical company will be investing £10 million to expand its UK business in Wrexham, creating up to 50 new jobs.
Wockhardt is a major NHS supplier of life-saving medicines such as insulin, diamorphine and heparins.
The multi-million pound investment will see a new state-of-the-art manufacturing facility installed at the Wrexham site – due to open in December 2016.
Wockhardt already employs 380 people in Wrexham and the new facility will provide an extra 40-50 jobs. The site is also set to boost sales for the company by around £150 million.
This comes as Prime Minister Theresa May visits India on a trade mission with 39 British small and medium-sized businesses to showcase the very best that UK business has to offer.
She will also use the visit to deliver on her pledge to create an economy that truly works for all, by introducing new and emerging enterprises, as well as more established players, to the key Indian market.
Prime Minister Theresa May said: “It’s great news that Wockhardt has decided to invest £10m into its Wrexham plant and create dozens of new jobs.
“For the near 400 people who work in the Wrexham manufacturing plant, and indeed the whole town, today’s announcement is a huge vote of confidence in the workers and the local economy.
“But I want to see much more investment in Wales. And that’s why I was so pleased to welcome two Welsh firms to my delegation for the trade trip to India, where they have been able to forge contacts and relationships with the investors of the future.”
Managing director of Wockhardt UK, Sirjiwan Singh, said: “It has been a great experience for Wockhardt to be in Wrexham for the last 13 years.
“This additional investment of £10m by Wockhardt into its sterile manufacturing and testing facility will ensure the global competitiveness of our operations and future manufacturing plans at Wrexham.
“Our Wrexham operations continue to be the European hub of Wockhardt Group.”